• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用硼化合物修饰亚油酰苯胺异羟肟酸作为人类II类组蛋白去乙酰化酶的抑制剂

Utilization of Boron Compounds for the Modification of Suberoyl Anilide Hydroxamic Acid as Inhibitor of Histone Deacetylase Class II Homo sapiens.

作者信息

Bakri Ridla, Parikesit Arli Aditya, Satriyanto Cipta Prio, Kerami Djati, Tambunan Usman Sumo Friend

机构信息

Bioinformatics Group, Department of Chemistry, Faculty of Mathematics and Science, University of Indonesia, Depok 16424, Indonesia.

Mathematics Computation Group, Department of Mathematics, Faculty of Mathematics and Science, University of Indonesia, Depok 16424, Indonesia.

出版信息

Adv Bioinformatics. 2014;2014:104823. doi: 10.1155/2014/104823. Epub 2014 Aug 24.

DOI:10.1155/2014/104823
PMID:25214833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4158260/
Abstract

Histone deacetylase (HDAC) has a critical function in regulating gene expression. The inhibition of HDAC has developed as an interesting anticancer research area that targets biological processes such as cell cycle, apoptosis, and cell differentiation. In this study, an HDAC inhibitor that is available commercially, suberoyl anilide hydroxamic acid (SAHA), has been modified to improve its efficacy and reduce the side effects of the compound. Hydrophobic cap and zinc-binding group of these compounds were substituted with boron-based compounds, whereas the linker region was substituted with p-aminobenzoic acid. The molecular docking analysis resulted in 8 ligands with ΔG binding value more negative than the standards, SAHA and trichostatin A (TSA). That ligands were analyzed based on the nature of QSAR, pharmacological properties, and ADME-Tox. It is conducted to obtain a potent inhibitor of HDAC class II Homo sapiens. The screening process result gave one best ligand, Nova2 (513246-99-6), which was then further studied by molecular dynamics simulations.

摘要

组蛋白去乙酰化酶(HDAC)在调节基因表达中起关键作用。HDAC抑制已发展成为一个有趣的抗癌研究领域,其靶向细胞周期、细胞凋亡和细胞分化等生物学过程。在本研究中,一种市售的HDAC抑制剂——辛二酰苯胺异羟肟酸(SAHA)已被修饰,以提高其疗效并降低该化合物的副作用。这些化合物的疏水帽和锌结合基团被硼基化合物取代,而连接区被对氨基苯甲酸取代。分子对接分析产生了8种配体,其ΔG结合值比标准品SAHA和曲古抑菌素A(TSA)更负。基于定量构效关系的性质、药理特性和药物代谢动力学及毒性对这些配体进行了分析。目的是获得一种有效的人类II类HDAC抑制剂。筛选过程的结果产生了一种最佳配体Nova2(513246-99-6),然后通过分子动力学模拟对其进行了进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a52/4158260/f71ce36a30fc/ABI2014-104823.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a52/4158260/b8d7feed4247/ABI2014-104823.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a52/4158260/42aa319e9a3f/ABI2014-104823.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a52/4158260/f71ce36a30fc/ABI2014-104823.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a52/4158260/b8d7feed4247/ABI2014-104823.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a52/4158260/42aa319e9a3f/ABI2014-104823.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a52/4158260/f71ce36a30fc/ABI2014-104823.003.jpg

相似文献

1
Utilization of Boron Compounds for the Modification of Suberoyl Anilide Hydroxamic Acid as Inhibitor of Histone Deacetylase Class II Homo sapiens.利用硼化合物修饰亚油酰苯胺异羟肟酸作为人类II类组蛋白去乙酰化酶的抑制剂
Adv Bioinformatics. 2014;2014:104823. doi: 10.1155/2014/104823. Epub 2014 Aug 24.
2
Molecular dynamics simulation of complex Histones Deacetylase (HDAC) Class II Homo Sapiens with suberoylanilide hydroxamic acid (SAHA) and its derivatives as inhibitors of cervical cancer.以辛二酰苯胺异羟肟酸(SAHA)及其衍生物作为宫颈癌抑制剂的人类II类组蛋白去乙酰化酶(HDAC)复合物的分子动力学模拟
Bioinformation. 2013 Jul 17;9(13):696-700. doi: 10.6026/97320630009696. Print 2013.
3
Identification of a better Homo sapiens Class II HDAC inhibitor through binding energy calculations and descriptor analysis.通过结合能计算和描述符分析鉴定更好的人类 Class II HDAC 抑制剂。
BMC Bioinformatics. 2010 Oct 15;11 Suppl 7(Suppl 7):S16. doi: 10.1186/1471-2105-11-S7-S16.
4
Design, synthesis, and evaluation of cyclic amide/imide-bearing hydroxamic acid derivatives as class-selective histone deacetylase (HDAC) inhibitors.含环酰胺/酰亚胺的异羟肟酸衍生物作为类别选择性组蛋白脱乙酰酶(HDAC)抑制剂的设计、合成与评价
Bioorg Med Chem. 2006 Nov 15;14(22):7625-51. doi: 10.1016/j.bmc.2006.07.008. Epub 2006 Jul 31.
5
Structural Requirements of HDAC Inhibitors: SAHA Analogues Modified at the C2 Position Display HDAC6/8 Selectivity.组蛋白去乙酰化酶(HDAC)抑制剂的结构要求:在C2位修饰的SAHA类似物表现出HDAC6/8选择性
ACS Med Chem Lett. 2017 Feb 7;8(3):281-286. doi: 10.1021/acsmedchemlett.6b00124. eCollection 2017 Mar 9.
6
MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cells.MLH1可保护结肠肿瘤细胞免受组蛋白去乙酰化酶抑制剂曲古抑菌素A诱导的耐药性。
Int J Oncol. 2009 Sep;35(3):631-40. doi: 10.3892/ijo_00000375.
7
Structural Requirements of Histone Deacetylase Inhibitors: SAHA Analogs Modified on the Hydroxamic Acid.组蛋白去乙酰化酶抑制剂的结构要求:基于异羟肟酸修饰的SAHA类似物
Arch Pharm (Weinheim). 2016 May;349(5):373-82. doi: 10.1002/ardp.201500472. Epub 2016 Apr 9.
8
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells.VPA 和 SAHA 诱导 AML1/ETO 阳性白血病细胞中组蛋白乙酰化的时间和残留特异性差异。
Epigenetics. 2013 Feb;8(2):210-9. doi: 10.4161/epi.23538. Epub 2013 Jan 15.
9
Synthesis of N-hydroxycinnamides capped with a naturally occurring moiety as inhibitors of histone deacetylase.用天然部分封端的 N-羟基肉桂酰胺作为组蛋白去乙酰化酶抑制剂的合成。
ChemMedChem. 2010 Apr 6;5(4):598-607. doi: 10.1002/cmdc.200900494.
10
The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.组蛋白去乙酰化酶抑制剂的结构要求:C4修饰的SAHA类似物具有HDAC6/HDAC8双重选择性。
Eur J Med Chem. 2018 Jan 1;143:1790-1806. doi: 10.1016/j.ejmech.2017.10.076. Epub 2017 Oct 31.

引用本文的文献

1
Borinostats: solid-phase synthesis of carborane-capped histone deacetylase inhibitors with a tailor-made selectivity profile.硼诺司他:具有定制选择性的碳硼烷封端组蛋白去乙酰化酶抑制剂的固相合成
Chem Sci. 2021 Aug 4;12(35):11873-11881. doi: 10.1039/d1sc02268g. eCollection 2021 Sep 15.
2
Exposing the Molecular Screening Method of Indonesian Natural Products Derivate as Drug Candidates for Cervical Cancer.揭示印度尼西亚天然产物衍生物作为宫颈癌候选药物的分子筛选方法。
Iran J Pharm Res. 2017 Summer;16(3):1113-1127.
3
Modification of -Adenosyl-l-Homocysteine as Inhibitor of Nonstructural Protein 5 Methyltransferase Dengue Virus Through Molecular Docking and Molecular Dynamics Simulation.

本文引用的文献

1
Screening of commercial cyclic peptides as inhibitor envelope protein dengue virus (DENV) through molecular docking and molecular dynamics.通过分子对接和分子动力学筛选商业环肽作为登革病毒包膜蛋白的抑制剂
Pak J Biol Sci. 2013 Dec 15;16(24):1836-48. doi: 10.3923/pjbs.2013.1836.1848.
2
Molecular dynamics simulation of complex Histones Deacetylase (HDAC) Class II Homo Sapiens with suberoylanilide hydroxamic acid (SAHA) and its derivatives as inhibitors of cervical cancer.以辛二酰苯胺异羟肟酸(SAHA)及其衍生物作为宫颈癌抑制剂的人类II类组蛋白去乙酰化酶(HDAC)复合物的分子动力学模拟
Bioinformation. 2013 Jul 17;9(13):696-700. doi: 10.6026/97320630009696. Print 2013.
3
通过分子对接和分子动力学模拟对 -腺苷-L-高半胱氨酸进行修饰作为登革病毒非结构蛋白5甲基转移酶的抑制剂
Drug Target Insights. 2017 Apr 20;11:1177392817701726. doi: 10.1177/1177392817701726. eCollection 2017.
4
Vaccine Design for H5N1 Based on B- and T-cell Epitope Predictions.基于B细胞和T细胞表位预测的H5N1疫苗设计
Bioinform Biol Insights. 2016 Apr 28;10:27-35. doi: 10.4137/BBI.S38378. eCollection 2016.
Computational exploration of zinc binding groups for HDAC inhibition.
计算探索组锌结合的 HDAC 抑制。
J Org Chem. 2013 May 17;78(10):5051-5. doi: 10.1021/jo400406g. Epub 2013 Apr 29.
4
Histone deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against chemoresistant cancer cells.新型连接单元连接区的组蛋白去乙酰化酶 (HDAC) 抑制剂揭示了对 HDAC4 和 HDAC5 的选择性特征,并且对耐药性癌细胞的活性得到改善。
J Med Chem. 2013 Jan 24;56(2):427-36. doi: 10.1021/jm301254q. Epub 2013 Jan 8.
5
Molecular modeling study on tunnel behavior in different histone deacetylase isoforms.不同组蛋白去乙酰化酶异构体中隧道行为的分子建模研究。
PLoS One. 2012;7(11):e49327. doi: 10.1371/journal.pone.0049327. Epub 2012 Nov 29.
6
Histone deacetylases in viral infections.病毒感染中的组蛋白去乙酰化酶。
Clin Epigenetics. 2010 Sep;1(1-2):13-24. doi: 10.1007/s13148-010-0003-5. Epub 2010 May 30.
7
Appraisal of GABA and PABA as linker: design and synthesis of novel benzamide based histone deacetylase inhibitors.评价 GABA 和 PABA 作为连接子:新型基于苯甲酰胺的组蛋白去乙酰化酶抑制剂的设计与合成。
Eur J Med Chem. 2012 Jul;53:390-7. doi: 10.1016/j.ejmech.2012.03.058. Epub 2012 Apr 11.
8
A novel series of l-2-benzyloxycarbonylamino-8-(2-pyridyl)-disulfidyloctanoic acid derivatives as histone deacetylase inhibitors: design, synthesis and molecular modeling study.一种新型系列 l-2-苄氧羰基氨基-8-(2-吡啶基)-二硫代辛酸衍生物作为组蛋白去乙酰化酶抑制剂的设计、合成及分子模拟研究。
Eur J Med Chem. 2012 Jun;52:111-22. doi: 10.1016/j.ejmech.2012.03.009. Epub 2012 Mar 15.
9
Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors.组蛋白去乙酰化酶在表观遗传调控中的作用:抑制剂研究中的新范例。
Clin Epigenetics. 2012 Mar 12;4(1):5. doi: 10.1186/1868-7083-4-5.
10
HDAC modulation and cell death in the clinic.组蛋白去乙酰化酶的调节与临床细胞死亡
Exp Cell Res. 2012 Jul 1;318(11):1229-44. doi: 10.1016/j.yexcr.2012.01.025. Epub 2012 Feb 3.